Selected research
Market Outlook & Growth Opportunities
Global Genomic Data Analysis Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Genomic Data Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Genomic Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genomic Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genomic Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Genomic Data Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Genomic Data Analysis Service market include Illumina, QIAGEN Digital Insights, BGI Genomics, Eurofins Genomics, Charles River Laboratories, CellCarta, CD Genomics, Fios Genomics and Basepair, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Genomic Data Analysis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genomic Data Analysis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genomic Data Analysis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genomic Data Analysis Service market.
Genomic Data Analysis Service Segment by Company
Illumina
QIAGEN Digital Insights
BGI Genomics
Eurofins Genomics
Charles River Laboratories
CellCarta
CD Genomics
Fios Genomics
Basepair
Golden Helix
DNAnexus
Seven Bridges(Velsera)
SOPHiA GENETICS
Fabric Genomics
Congenica
Novogene
GENEWIZ
Macrogen
AWS HealthOmics
Genomic Data Analysis Service Segment by Type
Cloud-Based SaaS Services
On-Premises Deployment Services
Genomic Data Analysis Service Segment by Application
Healthcare
Biomedicine
Scientific Research and Education
Agricultural Breeding
Others
Genomic Data Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Genomic Data Analysis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Genomic Data Analysis Service key companies, revenue, market share, and recent developments.
3. To split the Genomic Data Analysis Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Genomic Data Analysis Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Genomic Data Analysis Service significant trends, drivers, influence factors in global and regions.
6. To analyze Genomic Data Analysis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomic Data Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomic Data Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomic Data Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genomic Data Analysis Service industry.
Chapter 3: Detailed analysis of Genomic Data Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Genomic Data Analysis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Genomic Data Analysis Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based SaaS Services
- On-Premises Deployment Services
Applications
- Healthcare
- Biomedicine
- Scientific Research and Education
- Agricultural Breeding
- Others
Companies covered
- Illumina
- QIAGEN Digital Insights
- BGI Genomics
- Eurofins Genomics
- Charles River Laboratories
- CellCarta
- CD Genomics
- Fios Genomics
- Basepair
- Golden Helix
- DNAnexus
- Seven Bridges(Velsera)
- SOPHiA GENETICS
- Fabric Genomics
- Congenica
- Novogene
- GENEWIZ
- Macrogen
- AWS HealthOmics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Genomic Data Analysis Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Genomic Data Analysis Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Genomic Data Analysis Service Market Dynamics
- 2.1 Genomic Data Analysis Service Industry Trends
- 2.2 Genomic Data Analysis Service Industry Drivers
- 2.3 Genomic Data Analysis Service Industry Opportunities and Challenges
- 2.4 Genomic Data Analysis Service Industry Restraints
3 Genomic Data Analysis Service Market by Company
- 3.1 Global Genomic Data Analysis Service Company Revenue Ranking in 2025
- 3.2 Global Genomic Data Analysis Service Revenue by Company (2021-2026)
- 3.3 Global Genomic Data Analysis Service Company Ranking (2024-2026)
- 3.4 Global Genomic Data Analysis Service Company Manufacturing Base and Headquarters
- 3.5 Global Genomic Data Analysis Service Company Product Type and Application
- 3.6 Global Genomic Data Analysis Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Genomic Data Analysis Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Genomic Data Analysis Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Genomic Data Analysis Service Market by Type
- 4.1 Genomic Data Analysis Service Type Introduction
- 4.1.1 Cloud-Based SaaS Services
- 4.1.2 On-Premises Deployment Services
- 4.2 Global Genomic Data Analysis Service Sales Value by Type
- 4.2.1 Global Genomic Data Analysis Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Genomic Data Analysis Service Sales Value by Type (2021-2032)
- 4.2.3 Global Genomic Data Analysis Service Sales Value Share by Type (2021-2032)
5 Genomic Data Analysis Service Market by Application
- 5.1 Genomic Data Analysis Service Application Introduction
- 5.1.1 Healthcare
- 5.1.2 Biomedicine
- 5.1.3 Scientific Research and Education
- 5.1.4 Agricultural Breeding
- 5.1.5 Others
- 5.2 Global Genomic Data Analysis Service Sales Value by Application
- 5.2.1 Global Genomic Data Analysis Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Genomic Data Analysis Service Sales Value by Application (2021-2032)
- 5.2.3 Global Genomic Data Analysis Service Sales Value Share by Application (2021-2032)
6 Genomic Data Analysis Service Regional Value Analysis
- 6.1 Global Genomic Data Analysis Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Genomic Data Analysis Service Sales Value by Region (2021-2032)
- 6.2.1 Global Genomic Data Analysis Service Sales Value by Region: 2021-2026
- 6.2.2 Global Genomic Data Analysis Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Genomic Data Analysis Service Sales Value (2021-2032)
- 6.3.2 North America Genomic Data Analysis Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Genomic Data Analysis Service Sales Value (2021-2032)
- 6.4.2 Europe Genomic Data Analysis Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Genomic Data Analysis Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Genomic Data Analysis Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Genomic Data Analysis Service Sales Value (2021-2032)
- 6.6.2 South America Genomic Data Analysis Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Genomic Data Analysis Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Genomic Data Analysis Service Sales Value Share by Country, 2025 VS 2032
7 Genomic Data Analysis Service Country-level Value Analysis
- 7.1 Global Genomic Data Analysis Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Genomic Data Analysis Service Sales Value by Country (2021-2032)
- 7.2.1 Global Genomic Data Analysis Service Sales Value by Country (2021-2026)
- 7.2.2 Global Genomic Data Analysis Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Genomic Data Analysis Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Genomic Data Analysis Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Genomic Data Analysis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina Genomic Data Analysis Service Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 QIAGEN Digital Insights
- 8.2.1 QIAGEN Digital Insights Company Information
- 8.2.2 QIAGEN Digital Insights Business Overview
- 8.2.3 QIAGEN Digital Insights Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.2.4 QIAGEN Digital Insights Genomic Data Analysis Service Product Portfolio
- 8.2.5 QIAGEN Digital Insights Recent Developments
- 8.3 BGI Genomics
- 8.3.1 BGI Genomics Company Information
- 8.3.2 BGI Genomics Business Overview
- 8.3.3 BGI Genomics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.3.4 BGI Genomics Genomic Data Analysis Service Product Portfolio
- 8.3.5 BGI Genomics Recent Developments
- 8.4 Eurofins Genomics
- 8.4.1 Eurofins Genomics Company Information
- 8.4.2 Eurofins Genomics Business Overview
- 8.4.3 Eurofins Genomics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Eurofins Genomics Genomic Data Analysis Service Product Portfolio
- 8.4.5 Eurofins Genomics Recent Developments
- 8.5 Charles River Laboratories
- 8.5.1 Charles River Laboratories Company Information
- 8.5.2 Charles River Laboratories Business Overview
- 8.5.3 Charles River Laboratories Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Charles River Laboratories Genomic Data Analysis Service Product Portfolio
- 8.5.5 Charles River Laboratories Recent Developments
- 8.6 CellCarta
- 8.6.1 CellCarta Company Information
- 8.6.2 CellCarta Business Overview
- 8.6.3 CellCarta Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.6.4 CellCarta Genomic Data Analysis Service Product Portfolio
- 8.6.5 CellCarta Recent Developments
- 8.7 CD Genomics
- 8.7.1 CD Genomics Company Information
- 8.7.2 CD Genomics Business Overview
- 8.7.3 CD Genomics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.7.4 CD Genomics Genomic Data Analysis Service Product Portfolio
- 8.7.5 CD Genomics Recent Developments
- 8.8 Fios Genomics
- 8.8.1 Fios Genomics Company Information
- 8.8.2 Fios Genomics Business Overview
- 8.8.3 Fios Genomics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Fios Genomics Genomic Data Analysis Service Product Portfolio
- 8.8.5 Fios Genomics Recent Developments
- 8.9 Basepair
- 8.9.1 Basepair Company Information
- 8.9.2 Basepair Business Overview
- 8.9.3 Basepair Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Basepair Genomic Data Analysis Service Product Portfolio
- 8.9.5 Basepair Recent Developments
- 8.10 Golden Helix
- 8.10.1 Golden Helix Company Information
- 8.10.2 Golden Helix Business Overview
- 8.10.3 Golden Helix Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Golden Helix Genomic Data Analysis Service Product Portfolio
- 8.10.5 Golden Helix Recent Developments
- 8.11 DNAnexus
- 8.11.1 DNAnexus Company Information
- 8.11.2 DNAnexus Business Overview
- 8.11.3 DNAnexus Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.11.4 DNAnexus Genomic Data Analysis Service Product Portfolio
- 8.11.5 DNAnexus Recent Developments
- 8.12 Seven Bridges(Velsera)
- 8.12.1 Seven Bridges(Velsera) Company Information
- 8.12.2 Seven Bridges(Velsera) Business Overview
- 8.12.3 Seven Bridges(Velsera) Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Seven Bridges(Velsera) Genomic Data Analysis Service Product Portfolio
- 8.12.5 Seven Bridges(Velsera) Recent Developments
- 8.13 SOPHiA GENETICS
- 8.13.1 SOPHiA GENETICS Company Information
- 8.13.2 SOPHiA GENETICS Business Overview
- 8.13.3 SOPHiA GENETICS Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.13.4 SOPHiA GENETICS Genomic Data Analysis Service Product Portfolio
- 8.13.5 SOPHiA GENETICS Recent Developments
- 8.14 Fabric Genomics
- 8.14.1 Fabric Genomics Company Information
- 8.14.2 Fabric Genomics Business Overview
- 8.14.3 Fabric Genomics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Fabric Genomics Genomic Data Analysis Service Product Portfolio
- 8.14.5 Fabric Genomics Recent Developments
- 8.15 Congenica
- 8.15.1 Congenica Company Information
- 8.15.2 Congenica Business Overview
- 8.15.3 Congenica Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Congenica Genomic Data Analysis Service Product Portfolio
- 8.15.5 Congenica Recent Developments
- 8.16 Novogene
- 8.16.1 Novogene Company Information
- 8.16.2 Novogene Business Overview
- 8.16.3 Novogene Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Novogene Genomic Data Analysis Service Product Portfolio
- 8.16.5 Novogene Recent Developments
- 8.17 GENEWIZ
- 8.17.1 GENEWIZ Company Information
- 8.17.2 GENEWIZ Business Overview
- 8.17.3 GENEWIZ Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.17.4 GENEWIZ Genomic Data Analysis Service Product Portfolio
- 8.17.5 GENEWIZ Recent Developments
- 8.18 Macrogen
- 8.18.1 Macrogen Company Information
- 8.18.2 Macrogen Business Overview
- 8.18.3 Macrogen Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Macrogen Genomic Data Analysis Service Product Portfolio
- 8.18.5 Macrogen Recent Developments
- 8.19 AWS HealthOmics
- 8.19.1 AWS HealthOmics Company Information
- 8.19.2 AWS HealthOmics Business Overview
- 8.19.3 AWS HealthOmics Genomic Data Analysis Service Revenue and Gross Margin (2021-2026)
- 8.19.4 AWS HealthOmics Genomic Data Analysis Service Product Portfolio
- 8.19.5 AWS HealthOmics Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst